Authors:
Heath, PT
Booy, R
Azzopardi, HJ
Slack, MPE
Fogarty, J
Moloney, AC
Ramsay, ME
Moxon, ER
Citation: Pt. Heath et al., Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era, PEDIAT INF, 20(3), 2001, pp. 300-305
Authors:
Booy, R
Habibi, P
Nadel, S
de Munter, C
Britto, J
Morrison, A
Levin, M
Citation: R. Booy et al., Reduction in case fatality rate from meningococcal disease associated withimproved healthcare delivery, ARCH DIS CH, 85(5), 2001, pp. 386-390
Authors:
Heath, PT
Booy, R
Griffiths, H
Clutterbuck, E
Azzopardi, HJ
Slack, MPE
Fogarty, J
Moloney, AC
Moxon, ER
Citation: Pt. Heath et al., Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood, CLIN INF D, 31(4), 2000, pp. 973-980
Citation: J. Tully et al., The new system of review by multicentre research ethics committees: prospective study, BR MED J, 320(7243), 2000, pp. 1179-1182
Authors:
Heath, PT
Booy, R
Azzopardi, HJ
Slack, MPE
Bowen-Morris, J
Griffiths, H
Ramsay, ME
Deeks, JJ
Moxon, ER
Citation: Pt. Heath et al., Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom, J AM MED A, 284(18), 2000, pp. 2334-2340
Authors:
Moxon, ER
Heath, PT
Booy, R
Azzopardi, HJ
Slack, MPE
Ramsay, ME
Citation: Er. Moxon et al., The impact of Hib conjugate vaccines in preventing invasive H-influenzae diseases in the UK, VACCINE, 17, 1999, pp. S11-S13
Authors:
Hermans, PWM
Hibberd, ML
Booy, R
Daramola, O
Hazelzet, JA
de Groot, R
Levin, M
Citation: Pwm. Hermans et al., 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease, LANCET, 354(9178), 1999, pp. 556-560
Authors:
Hibberd, ML
Sumiya, M
Summerfield, JA
Booy, R
Levin, M
Citation: Ml. Hibberd et al., Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease, LANCET, 353(9158), 1999, pp. 1049-1053